Goldman Capital Management’s Xtant Medical Holdings XTNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-3,583
Closed -$31K 27
2017
Q3
$31K Sell
3,583
-5,834
-62% -$52.2K 0.03% 23
2017
Q2
$75K Sell
9,417
-9,000
-49% -$59.8K 0.08% 23
2017
Q1
$137K Sell
18,417
-38,465
-68% -$236K 0.13% 25
2016
Q4
$375K Sell
56,882
-20,091
-26% -$173K 0.33% 21
2016
Q3
$1.04M Buy
76,973
+4,446
+6% +$81.8K 0.84% 17
2016
Q2
$1.66M Buy
72,527
+10,759
+17% +$277K 1.43% 14
2016
Q1
$2.01M Buy
61,768
+8,057
+15% +$257K 1.52% 14
2015
Q4
$1.8M Buy
53,711
+10,003
+23% +$352K 1.4% 14
2015
Q3
$1.71M Buy
43,708
+2,091
+5% +$81.8K 1.22% 15
2015
Q2
$1.75M Buy
41,617
+9,792
+31% +$499K 1.09% 17
2015
Q1
$1.57M Sell
31,825
-6,660
-17% -$268K 0.92% 19
2014
Q4
$1.4M Sell
38,485
-1,198
-3% -$49.8K 0.77% 17
2014
Q3
$2.13M Buy
39,683
+22,266
+128% +$1.48M 1.07% 16
2014
Q2
$1.41M Buy
17,417
+5,709
+49% +$484K 0.7% 21
2014
Q1
$978K Sell
11,708
-1,417
-11% -$112K 0.53% 23
2013
Q4
$788K Sell
13,125
-7,741
-37% -$495K 0.43% 21
2013
Q3
$1.68M Buy
20,866
+1,007
+5% +$72.3K 1.11% 20
2013
Q2
$1.07M Buy
+19,859
New +$1.64M 0.61% 23

Other funds holding XTNT

Goldman Capital Management's XTNT Position: Q4 2017 in Review

Goldman Capital Management sold out of Xtant Medical Holdings (XTNT) in Q4 2017, closing a stake of 3,583 shares — an estimated $31K sold.

Goldman Capital Management first reported a position in XTNT in Q2 2013 and held it in 18 quarters. The position peaked at $2.13M in Q3 2014. 19 funds tracked by Wall St. Rank hold XTNT as of Q4 2017.

  • Goldman Capital Management reported no remaining Xtant Medical Holdings position as of Q4 2017 after selling out during the quarter.
  • Goldman Capital Management sold 3,583 Xtant Medical Holdings shares in Q4 2017, an estimated $31K.
  • Goldman Capital Management first reported a position in Xtant Medical Holdings in Q2 2013 and held it in 18 quarters.
  • Goldman Capital Management's Xtant Medical Holdings position peaked at $2.13M in Q3 2014.
  • 19 funds tracked by Wall St. Rank held Xtant Medical Holdings as of Q4 2017.

Based on Goldman Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.